Arab Finance: Eva Pharma signed an agreement with the Saudi Authority for Industrial Cities and Technology Zones (MODON) to establish an integrated industrial complex for pharmaceutical research and manufacturing in Saudi Arabia with SAR 500 million in investments, the Saudi News Agency reported on September 28th.
The project will be built on a 50,000-square-meter land plot in Sudair Industrial and Business City.
The complex targets the launch of more than 150 pharmaceutical products, equivalent to 990 million units annually.
Moreover, it will include five factories for the production of biopharmaceuticals, oncology treatments, advanced tablets and capsules, as well as immunosuppressants and vaccines.